Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management
about
The role of peroxisome proliferator-activated receptors in carcinogenesis and chemopreventionRole of retinoids in the prevention and treatment of colorectal cancerDifferentiation therapy of leukemia: 3 decades of development.Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry.Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alphaGenetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrenceNitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Decreased RXRα is Associated with Increased β-Catenin/TCF4 in (56)Fe-Induced Intestinal Tumors.Prognostic role of PPAR-γ and PTEN in the renal cell carcinoma.Targeting truncated RXRα for cancer therapy.Targeting truncated retinoid X receptor-α by CF31 induces TNF-α-dependent apoptosis.PPARgamma in Neuroblastoma.A Role for the PPARgamma in Cancer Therapy.PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsPeroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathwaysPPARs Mediate Lipid Signaling in Inflammation and Cancer.Retinoid and thiazolidinedione therapies in melanoma: an analysis of differential response based on nuclear hormone receptor expressionSynergistic Effects of PPARgamma Ligands and Retinoids in Cancer Treatment.Cyclooxygenase-2 expression in the tumor environment is associated with poor prognosis in colorectal cancer patientsAnalysis of transcription profile to reveal altered signaling pathways following the overexpression of human desumoylating isopeptidase 2 in pancreatic cancer cells.Peroxisome proliferator-activated receptor γ and colorectal cancer.PPAR gamma, bioactive lipids, and cancer progression.Acyclic retinoid in chemoprevention of hepatocellular carcinoma: Targeting phosphorylated retinoid X receptor-α for prevention of liver carcinogenesis.Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling.Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.Posttranslational Modifications of Lipid-Activated Nuclear Receptors: Focus on Metabolism.Oroxylin A has therapeutic potential in acute myelogenous leukemia by dual effects targeting PPARγ and RXRα.Antitumoral effects of 9-cis retinoic acid in adrenocortical cancer.PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.PPARγ in Inflammatory Bowel Disease.Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzene.ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia.Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells.Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis.RXRα enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC).Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway.Synergistic growth inhibition in HL-60 cells by the combination of acyclic retinoid and vitamin K2.
P2860
Q24601222-05262937-531E-4FC3-8581-91D7FF5C6FE5Q26781463-5F90B5D2-2A8A-4DE6-8D7F-8CDA506FEADBQ33409795-46B8A2E7-9DBA-4D23-9988-B39A7DF64CF4Q34042369-61F0ADFF-452A-4B33-8C9A-221BF3FBECBBQ34251206-B5432DBD-E7A1-4A1A-A409-CFA4150A531CQ34483364-F862A0DC-DA6E-41A8-9A8C-61424B87F9B8Q35612396-10DD67A4-29E8-4144-B689-4BB11F130723Q35667311-BBDE0F02-3FFE-43D5-80B2-3375F086A686Q36133903-CB871BBF-13C7-4996-A736-78E261630783Q36375196-F25E7A00-C639-4339-9BB4-256521EBE963Q36398740-7D99AF53-0E52-493C-B9AB-3931D03C11B7Q36510879-7868243A-0C6A-4860-8088-2A32D51E2D47Q36678476-E8CA795E-9E48-4F7A-91DE-9F54CD8A7144Q36691611-22EACAB8-5FB9-4E79-AC98-0675575EA694Q36859555-5173961C-3090-4494-BE0B-72E86DD0885CQ37001526-C6779DB0-5BF2-4D99-B3FD-40ACAF755866Q37021709-5E153F16-3533-49CB-BF5C-88858E8E132CQ37126227-B0268D1C-F765-4A26-AF73-B177B37EC226Q37182802-5BA9F95C-9F64-464B-B633-373DDBC43760Q37211803-A75B4907-856B-4A6D-B9BB-78E926A10452Q37582109-98496067-6E81-4CEA-8D78-1EBCBAFF9030Q37821269-83D149D4-1A30-4C89-B814-CC29CBDC9FCDQ37971590-54549EF0-E4B3-4889-9C08-41AE248FD96AQ38066478-6A00E464-DF0E-438A-993F-A381D2ADD665Q38504789-CD715672-A492-4EE0-B4F9-B08645F4724FQ38730810-9E1E0B52-7DB1-4611-BF24-5E5EAD7C44F2Q39031477-990EC7A8-C0DA-4881-892B-7FE8B1221C0DQ39112113-48B7A27A-0A27-4856-A66A-C4667FCA137DQ39134041-4D37BCC7-E508-444B-9A7A-C1E3C3750C91Q41677812-4ECBDCE5-B241-496A-BC12-E5C2E7639314Q42038488-4D4ADACA-490F-4456-914F-1D4D37C40F19Q42109758-425BA7AD-D0D6-45A8-A758-92632690866DQ42220799-1244F889-CE48-4E72-AD52-80344FCED70AQ42261468-98993309-9C74-4CD4-8AD0-C854B8B18CF3Q47152429-23A54C85-C6A5-44EC-9335-2DED29B70E5FQ47739412-8D75FBD4-7F38-4857-A897-0DE0C98B2BDDQ49935401-000D83A8-EA88-4513-8AF8-2C34241ABD30Q50068821-8EC4B462-F1AB-4D72-81D0-8E636A611BAFQ50443179-48A81F93-7BCF-4807-8C0B-54F54F7FA8B6
P2860
Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Synergistic effects of RXR alp ...... et for colon cancer management
@ast
Synergistic effects of RXR alp ...... et for colon cancer management
@en
type
label
Synergistic effects of RXR alp ...... et for colon cancer management
@ast
Synergistic effects of RXR alp ...... et for colon cancer management
@en
prefLabel
Synergistic effects of RXR alp ...... et for colon cancer management
@ast
Synergistic effects of RXR alp ...... et for colon cancer management
@en
P2093
P2860
P356
P1433
P1476
Synergistic effects of RXR alp ...... et for colon cancer management
@en
P2093
Hiroshi Araki
Hisashi Tsurumi
Hisataka Moriwaki
I Bernard Weinstein
Kenji Yamazaki
Masahito Shimizu
Masataka Okuno
Nobuhiro Kanemura
Rie Matsushima-Nishiwaki
P2860
P304
P356
10.1136/GUT.2007.129858
P407
P577
2007-06-29T00:00:00Z